(CHD) Church & Dwight - Overview

Sector: Consumer Defensive | Industry: Household & Personal Products | Exchange: NYSE (USA) | Market Cap: 22.778m USD | Total Return: -8.8% in 12m

Household Cleaners, Personal Care, Pet Supplies, Animal Feed

Total Rating 59

Safety 88

Buy Signal 0.25

Household & Personal Products
Industry Rotation: -3.9

Market Cap: 22.8B
Avg Turnover: 184M USD

ATR: 2.14%
Peers RS (IBD): 68.2

Risk 5d forecast

Volatility19.1%

Rel. Tail Risk0.26%

Reward TTM

Sharpe Ratio-0.43

Alpha-9.00

Character TTM

Beta-0.035

Beta Downside-0.367

Drawdowns 3y

Max DD27.28%

CAGR/Max DD0.11

EPS (Earnings per Share)

EPS CAGR: 0.95%
EPS Trend: -2.5%

Last SUE: 0.08
Qual. Beats: 0

Revenue

Rev. CAGR: 6.53%
Rev. Trend: 89.1%

Last SUE: 0.30
Qual. Beats: 0

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Description: CHD Church & Dwight

Church & Dwight Co., Inc. (CHD) develops, manufactures, and markets a range of consumer and specialty products. The company operates in three segments: Consumer Domestic, Consumer International, and Specialty Products. This diversified approach is common among established consumer goods companies, allowing for market penetration across various geographies and product categories.

Its brand portfolio includes ARM & HAMMER (baking soda, cat litter), OXICLEAN (stain removers), BATISTE (dry shampoos), WATERPIK (water flossers), THERABREATH (oral care), HERO (acne treatment), TOUCHLAND (hand sanitizers), and TROJAN (condoms). Other notable brands are FIRST RESPONSE (pregnancy tests), NAIR (depilatories), ORAJEL (oral analgesics), XTRA (laundry detergents), and ZICAM (cold relief). These brands span household, personal care, and health & wellness categories, demonstrating a broad market reach within the consumer staples sector.

The Specialty Products division focuses on animal and food productivity, offering products like ARM & HAMMER baking soda as a feed additive for dairy cows, BIO-CHLOR, FERMENTEN, CELMANAX, and CERTILLUS for livestock. These products are sold to industrial customers and livestock producers through distributors. Consumer products are distributed through various retail channels, including supermarkets, mass merchandisers, drugstores, and e-commerce platforms.

For more detailed financial analysis, consider exploring Church & Dwights performance data on ValueRay.

Headlines to Watch Out For

Household product demand drives domestic revenue
International expansion boosts sales growth
Raw material costs impact profit margins
Acquisition strategy fuels brand portfolio expansion
Consumer spending trends influence product sales

Piotroski VR‑10 (Strict) 8.5

Net Income: 736.8m TTM > 0 and > 6% of Revenue
FCF/TA: 0.12 > 0.02 and ΔFCF/TA 1.27 > 1.0
NWC/Revenue: 1.60% < 20% (prev 15.14%; Δ -13.54% < -1%)
CFO/TA 0.14 > 3% & CFO 1.22b > Net Income 736.8m
Net Debt (1.80b) to EBITDA (1.30b): 1.38 < 3
Current Ratio: 1.07 > 1.5 & < 3
Outstanding Shares: last quarter (239.6m) vs 12m ago -3.19% < -2%
Gross Margin: 44.73% > 18% (prev 0.46%; Δ 4.43k% > 0.5%)
Asset Turnover: 69.72% > 50% (prev 68.75%; Δ 0.97% > 0%)
Interest Coverage Ratio: 11.05 > 6 (EBITDA TTM 1.30b / Interest Expense TTM 95.2m)

Altman Z'' 4.85

A: 0.01 (Total Current Assets 1.60b - Total Current Liabilities 1.50b) / Total Assets 8.91b
B: 0.76 (Retained Earnings 6.77b / Total Assets 8.91b)
C: 0.12 (EBIT TTM 1.05b / Avg Total Assets 8.90b)
D: 1.43 (Book Value of Equity 7.04b / Total Liabilities 4.91b)
Altman-Z'' Score: 4.85 = AA

Beneish M -2.99

DSRI: 0.97 (Receivables 593.4m/600.8m, Revenue 6.20b/6.11b)
GMI: 1.02 (GM 44.73% / 45.69%)
AQI: 1.13 (AQ_t 0.73 / AQ_t-1 0.64)
SGI: 1.02 (Revenue 6.20b / 6.11b)
TATA: -0.05 (NI 736.8m - CFO 1.22b) / TA 8.91b)
Beneish M-Score: -2.99 (Cap -4..+1) = A

What is the price of CHD shares? As of April 14, 2026, the stock is trading at USD 95.03 with a total of 862,076 shares traded.
Over the past week, the price has changed by +2.04%, over one month by -2.78%, over three months by +8.36% and over the past year by -8.82%.

Is CHD a buy, sell or hold? Church & Dwight has received a consensus analysts rating of 3.42. Therefor, it is recommend to hold CHD.

StrongBuy: 7
Buy: 2
Hold: 10
Sell: 4
StrongSell: 1

What are the forecasts/targets for the CHD price?

Analysts Target Price	102.3	7.6%

Church & Dwight (CHD) - Fundamental Data Overview as of 11 April 2026

P/E Trailing = 31.1197
P/E Forward = 24.6914
P/S = 3.672
P/B = 5.4954
P/EG = 2.9013
Revenue TTM = 6.20b USD
EBIT TTM = 1.05b USD
EBITDA TTM = 1.30b USD
Long Term Debt = 2.21b USD (from longTermDebt, last quarter)
Short Term Debt = 28.9m USD (from shortTermDebt, two quarters ago)
Debt = 2.21b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.80b USD (from netDebt column, last quarter)
Enterprise Value = 24.57b USD (22.78b + Debt 2.21b - CCE 409.0m)
Interest Coverage Ratio = 11.05 (Ebit TTM 1.05b / Interest Expense TTM 95.2m)
EV/FCF = 22.48x (Enterprise Value 24.57b / FCF TTM 1.09b)
FCF Yield = 4.45% (FCF TTM 1.09b / Enterprise Value 24.57b)
FCF Margin = 17.62% (FCF TTM 1.09b / Revenue TTM 6.20b)
Net Margin = 11.88% (Net Income TTM 736.8m / Revenue TTM 6.20b)
Gross Margin = 44.73% ((Revenue TTM 6.20b - Cost of Revenue TTM 3.43b) / Revenue TTM)
Gross Margin QoQ = 45.85% (prev 45.06%)
Tobins Q-Ratio = 2.76 (Enterprise Value 24.57b / Total Assets 8.91b)
Interest Expense / Debt = 1.12% (Interest Expense 24.6m / Debt 2.21b)
Taxrate = 23.71% (44.6m / 188.1m)
NOPAT = 802.6m (EBIT 1.05b * (1 - 23.71%))
Current Ratio = 1.07 (Total Current Assets 1.60b / Total Current Liabilities 1.50b)
Debt / Equity = 0.55 (Debt 2.21b / totalStockholderEquity, last quarter 4.00b)
Debt / EBITDA = 1.38 (Net Debt 1.80b / EBITDA 1.30b)
Debt / FCF = 1.64 (Net Debt 1.80b / FCF TTM 1.09b)
Total Stockholder Equity = 4.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.28% (Net Income 736.8m / Total Assets 8.91b)
RoE = 17.16% (Net Income TTM 736.8m / Total Stockholder Equity 4.29b)
RoCE = 16.19% (EBIT 1.05b / Capital Employed (Equity 4.29b + L.T.Debt 2.21b))
RoIC = 12.35% (NOPAT 802.6m / Invested Capital 6.50b)
WACC = 5.42% (E(22.78b)/V(24.98b) * Re(5.86%) + D(2.21b)/V(24.98b) * Rd(1.12%) * (1-Tc(0.24)))
Discount Rate = 5.86% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -33.33 | Cagr: -1.51%
[DCF] Terminal Value 87.34% ; FCFF base≈1.05b ; Y1≈1.17b ; Y5≈1.53b
[DCF] Fair Price = 182.5 (EV 45.02b - Net Debt 1.80b = Equity 43.22b / Shares 236.9m; r=6.0% [WACC]; 5y FCF grow 13.10% → 3.0% )
EPS Correlation: -2.46 | EPS CAGR: 0.95% | SUE: 0.08 | # QB: 0
Revenue Correlation: 89.06 | Revenue CAGR: 6.53% | SUE: 0.30 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.98 | Chg7d=-0.001 | Chg30d=-0.001 | Revisions Net=-1 | Analysts=17
EPS current Year (2026-12-31): EPS=3.75 | Chg7d=-0.010 | Chg30d=-0.017 | Revisions Net=-1 | Growth EPS=+6.3% | Growth Revenue=-0.7%
EPS next Year (2027-12-31): EPS=4.01 | Chg7d=-0.019 | Chg30d=-0.029 | Revisions Net=-3 | Growth EPS=+6.9% | Growth Revenue=+3.6%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.7% (Discount Rate 7.9% - Earnings Yield 3.2%)
[Growth] Growth Spread = -4.5% (Analyst 0.3% - Implied 4.7%)

External Resources

Dataroma Stockcircle